ABOUT US

Company Profile

Company

Algal Bio Co., Ltd.

We strve to be a leading algae based biotech (algal-bio) platform for a better future.

Location

[Head office]
Tokatsu Techno Plaza 301
5-4-6 Kashiwanoha, Kashiwa,
Chiba 277-0882, Japan
Phone:04-7138-6207 FAX:04-7138-6203
[Office / Laboratory]
Todai-Kashiwa Venture Plaza,
5-4-19 Kashiwanoha, Kashiwa,
Chiba, 277-0882, Japan

Map
Cultivation and
Production Technology
Center
Tokatsu Techno Plaza(Kashiwanoha,Kashiwa City)
Todai-kashiwa Venture Plaza(Kashiwanoha,Kashiwa City)
Culture Technology Center (Funato, Kashiwa City)
Established
March 1, 2018
CEO
Amane Kimura
Key Investors
The University of Tokyo Edge Capital Partners Co., Ltd. (UTEC)
Japan Science and Technology Agency (JST)
Abies Ventures, Inc.
Kyoto University Innovation Capital Co., Ltd.
Chiba Bank Capital Co., Ltd.
Japan Material Technologies Corporation

MANAGEMENT TEAM

Chief Executive Officer/Amane Kimura
[Career] Amane previously led investment and management of "Food and Agriculture" and "Wellness" at Mitsui & Co., Ltd., one of the largest Japanese investment firms. While he was stationed in the United States, he gained a lot of experience in global food tech venture investment and was involved as an observer at the board of directors of Beyond Meat, an alternative protein start-up company. He joined Algalbio Co., Ltd. as COO in 2020. Graduated from Hitotsubashi University Faculty of Commerce.
Chief Revenue Officer / Chief Technology Officer/Masaru Yasui
[Career] Masaru was previously with Idemitsu Kosan Co.,Ltd., one of the leading energy companies in Japan. He held important positions in the fields of R&D, Business Development and Innovation . Experienced as an independent director of portfolio companies in Agtech field. In 2019, he became the general manager of the business development of Algalbio Co., Ltd.. Graduated from Shinshu University Graduate School (Engineering) Waseda University Graduate School (MBA)
Chief Scientific Officer/Tsuyoshi Takeshita
[Career]After working as a specially appointed researcher at the University of Tokyo, he founded Algalbio Co., Ltd. in March 2018. The University of Tokyo Graduate School (Life Science)
Director / Keisuke Ide
A partner at UTEC (The University of Tokyo Edge Capital Partners) and joined our board in Dec. 2018. [Career]Keisuke started his career in Silicon Valley as an engineer at KLA-Tencor Corp. in San Jose. He then joined The McKenna Group led by Regis McKenna, as a consultant in technology marketing. After returning to Tokyo, he served as a director in a startup company designing ASICs, before joining Globis Capital Partners as a venture capitalist. He has a BS (Tau Beta Pi) in Systems Engineering from University of Virginia, and MS Honors in Management Science and Engineering (formerly of Engineering Economic Systems) from Stanford University. He was listed on Forbes Japan Midas List in 2017.
Auditor /Maiko Katadae
A partner at UTEC (The University of Tokyo Edge Capital Partners) and joined our board in May. 2021. [Career]Maiko graduated from the Department of Science at Ochanomizu University, completed the Master’s program in Chemistry and PhD in Science at the Department of Biological Sciences, Graduate School of Science in the University of Tokyo. She was selected as one of the 100 Influential People of Japan in 2013 by the Nikkei Business Magazine and won the Semi-Grand Prize for Woman of the Year 2014 by Nikkei.

HISTORY

2018. 3
Algalbio Co., Ltd. was established
2018. 4
Seed Round (JPY 48M)
2018. 10
Opened a research laboratory at the Kashiwa Venture Plaza
2019. 4
Opened a Culture Technology Center (Funato, Kashiwa City)
2019. 7
Himawari Venture Development Fund "2019 Grant Project"
2019.11
Series A Round (JPY 400M)
2019.11
Selected as one of Forbes Japan "200 SUPERSTAR ENTREPRENEURS"
2020.5
Selected by NEDO "Seed-stage Technology-based Startups"
2020.11
Selected for the 2nd consecutive year in Forbes Japan "200 SUPERSTAR ENTREPRENEURS"